A Retrospective Study on Erythropoiesis Stimulating Agent Dose Reducing Potential of an Anti‐Platelet Activation Membrane Dialyzer in Hemodialysis Patients

Our previous small‐scale trial demonstrated an erythropoiesis stimulating agent (ESA)‐sparing potential of the TORAYLIGHT NV (NV) dialyzer in hemodialysis patients with high interleukin‐6 levels. We now retrospectively explored this ESA‐sparing potential of the NV dialyzer in 122 and 129 prevalent d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakuta, Takatoshi, Ishida, Mari, Komaba, Hirotaka, Suzuki, Hajime, Fukagawa, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379541/
https://www.ncbi.nlm.nih.gov/pubmed/30311350
http://dx.doi.org/10.1111/1744-9987.12759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379541/
https://www.ncbi.nlm.nih.gov/pubmed/30311350
http://dx.doi.org/10.1111/1744-9987.12759

Ejemplares similares